443 related articles for article (PubMed ID: 12654166)
1. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study.
Tully AM; Roche HM; Doyle R; Fallon C; Bruce I; Lawlor B; Coakley D; Gibney MJ
Br J Nutr; 2003 Apr; 89(4):483-9. PubMed ID: 12654166
[TBL] [Abstract][Full Text] [Related]
2. Depression and adipose and serum cholesteryl ester polyunsaturated fatty acids in the survivors of the seven countries study population of Crete.
Mamalakis G; Jansen E; Cremers H; Kiriakakis M; Tsibinos G; Kafatos A
Eur J Clin Nutr; 2006 Aug; 60(8):1016-23. PubMed ID: 16482070
[TBL] [Abstract][Full Text] [Related]
3. Fatty acids in serum cholesteryl esters in relation to asthma and lung function in children.
Bolte G; Kompauer I; Fobker M; Cullen P; Keil U; Mutius E; Weiland SK
Clin Exp Allergy; 2006 Mar; 36(3):293-302. PubMed ID: 16499639
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
[TBL] [Abstract][Full Text] [Related]
5. Nutritional status of patients with Alzheimer's disease: a 1-year study.
Spindler AA; Renvall MJ; Nichols JF; Ramsdell JW
J Am Diet Assoc; 1996 Oct; 96(10):1013-8. PubMed ID: 8841163
[TBL] [Abstract][Full Text] [Related]
6. Essential and long-chain polyunsaturated fatty acid status and fatty acid composition of breast milk of lactating adolescents.
Meneses F; Torres AG; Trugo NM
Br J Nutr; 2008 Nov; 100(5):1029-37. PubMed ID: 18307833
[TBL] [Abstract][Full Text] [Related]
7. Unresolved issues in the link between docosahexaenoic acid and Alzheimer's disease.
Plourde M; Fortier M; Vandal M; Tremblay-Mercier J; Freemantle E; Bégin M; Pifferi F; Cunnane SC
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):301-8. PubMed ID: 18036804
[TBL] [Abstract][Full Text] [Related]
8. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
9. N-6 and n-3 fatty acid cholesteryl esters in relation to incident stroke in a Dutch adult population: a nested case-control study.
De Goede J; Verschuren WM; Boer JM; Kromhout D; Geleijnse JM
Nutr Metab Cardiovasc Dis; 2013 Aug; 23(8):737-43. PubMed ID: 22633188
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease study.
Irving GF; Freund-Levi Y; Eriksdotter-Jönhagen M; Basun H; Brismar K; Hjorth E; Palmblad J; Vessby B; Vedin I; Wahlund LO; Cederholm T
J Am Geriatr Soc; 2009 Jan; 57(1):11-7. PubMed ID: 19054188
[TBL] [Abstract][Full Text] [Related]
11. Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia.
Watanabe T; Miyazaki A; Katagiri T; Yamamoto H; Idei T; Iguchi T
J Am Geriatr Soc; 2005 Oct; 53(10):1748-53. PubMed ID: 16181175
[TBL] [Abstract][Full Text] [Related]
12. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
[TBL] [Abstract][Full Text] [Related]
13. Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis.
Friedman AN; Moe SM; Perkins SM; Li Y; Watkins BA
Am J Kidney Dis; 2006 Jun; 47(6):1064-71. PubMed ID: 16731302
[TBL] [Abstract][Full Text] [Related]
14. A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease.
Selley ML
Neurobiol Aging; 2007 Dec; 28(12):1834-9. PubMed ID: 16996649
[TBL] [Abstract][Full Text] [Related]
15. Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease.
Sijben JW; Calder PC
Proc Nutr Soc; 2007 May; 66(2):237-59. PubMed ID: 17466105
[TBL] [Abstract][Full Text] [Related]
16. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
17. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
[TBL] [Abstract][Full Text] [Related]
18. Moderate intake of myristic acid in sn-2 position has beneficial lipidic effects and enhances DHA of cholesteryl esters in an interventional study.
Dabadie H; Peuchant E; Bernard M; LeRuyet P; Mendy F
J Nutr Biochem; 2005 Jun; 16(6):375-82. PubMed ID: 15936650
[TBL] [Abstract][Full Text] [Related]
19. Low serum VEGF levels are associated with Alzheimer's disease.
Mateo I; Llorca J; Infante J; Rodríguez-Rodríguez E; Fernández-Viadero C; Peña N; Berciano J; Combarros O
Acta Neurol Scand; 2007 Jul; 116(1):56-8. PubMed ID: 17587256
[TBL] [Abstract][Full Text] [Related]
20. Serum phospholipid fatty acids, adipose tissue, and metabolic markers in obese adolescents.
Karlsson M; Mårild S; Brandberg J; Lönn L; Friberg P; Strandvik B
Obesity (Silver Spring); 2006 Nov; 14(11):1931-9. PubMed ID: 17135608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
